Found primarily uses compounded semaglutide and tirzepatide, which are chemically equivalent but manufactured by licensed 503A compounding pharmacies rather than pharmaceutical companies
Handle setbacks: Everyone has off days
Innovation is moving fast in the weight loss patch market
Tomovic K, Lazarevic J, Kocic G, Deljanin-Ilic M, Anderluh M, Smelcerovic A
365 Specific to GI function, tVNS also has been shown in humans to induce gastric slowing by reducing myoelectrical signaling, reduce the development of and reverse established acid-induced esophageal hypersensitivity, improve gastrointestinal symptoms in Parkinsons disease, and improve biomarkers related to postoperative ileus